ALNYLAM PHARMACEUTICALS, INC. Total Liabilities 2009-2025 | ALNY
What is total liabilities?
Total liabilities can be defined as the sum of all current and non-current debts and obligations owed by the company.
What is ALNYLAM PHARMACEUTICALS, INC.'s current total liabilities?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual total liabilities for 2025 was $4.18B, a 0.10% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. total liabilities for the quarter ending December 31, 2025 was $4.18B.
What was ALNYLAM PHARMACEUTICALS, INC.'s total liabilities in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual total liabilities for 2024 was $4.17B, a 3.02% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s total liabilities in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual total liabilities for 2023 was $4.05B, a 9.34% increase from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year total liabilities CAGR?
ALNYLAM PHARMACEUTICALS, INC. total liabilities grew at a compound annual growth rate (CAGR) of 11.81% from FY2020 to FY2025, going from $2.39B to $4.18B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $4.18B | +0.1% | 10-K |
| FY2024 | $4.17B | +3.0% | 10-K |
| FY2023 | $4.05B | +9.3% | 10-K |
| FY2022 | $3.70B | +21.3% | 10-K |
| FY2021 | $3.06B | +27.8% | 10-K |
| FY2020 | $2.39B | +150.0% | 10-K |
| FY2019 | $956.4M | +250.6% | 10-K |
| FY2018 | $272.8M | +19.5% | 10-K |
| FY2017 | $228.3M | -33.4% | 10-K |
| FY2016 | $342.6M | +181.3% | 10-K |
| FY2015 | $121.8M | -15.0% | 10-K |
| FY2014 | $143.3M | -4.6% | 10-K |
| FY2013 | $150.2M | -2.1% | 10-K |
| FY2012 | $153.5M | -6.4% | 10-K |
| FY2011 | $163.9M | -30.3% | 10-K |
| FY2010 | $235.0M | -22.5% | 10-K |
| FY2009 | $303.4M | - | 10-K |